Aquatic Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-198,000
| Closed | -$13.9M | – | 1345 |
|
|
2024
Q3 | $13.9M | Buy |
+198,000
| New | +$13.9M | 0.36% | 77 |
|
|
2024
Q2 | – | Sell |
-16,000
| Closed | -$1.4M | – | 1247 |
|
|
2024
Q1 | $1.4M | Sell |
16,000
-26,500
| -62% | -$2.31M | 0.05% | 326 |
|
|
2023
Q4 | $4.1M | Buy |
+42,500
| New | +$4.1M | 0.1% | 197 |
|
|
2023
Q3 | – | Sell |
-6,100
| Closed | -$529K | – | 1264 |
|
|
2023
Q2 | $529K | Sell |
6,100
-32,100
| -84% | -$2.78M | 0.03% | 438 |
|
|
2023
Q1 | $3.72M | Buy |
+38,200
| New | +$3.72M | 0.23% | 116 |
|
|
2022
Q4 | – | Sell |
-21,600
| Closed | -$1.83M | – | 1378 |
|
|
2022
Q3 | $1.83M | Buy |
+21,600
| New | +$1.83M | 0.18% | 161 |
|
|
2022
Q2 | – | Sell |
-700
| Closed | -$54K | – | 1213 |
|
|
2022
Q1 | $54K | Buy |
+700
| New | +$54K | 0.08% | 268 |
|